1. dianamoonblade1
2. nomaam4565
3. pierceton
4. SugarDaddy
5. nshsn8vjkdpyvqf
1.SugarDaddy 10/18/2017
{Image}
2.nomaam4565 01/29/2018
$144 PT
3.pierceton 02/18/2018
AbbVie Presents New Positive Late-Breaking Data from Two Phase 3 Psoriasis Trials of Risankizumab at the 2018 American Academy of Dermatology Annual Meeting
4.dianamoonblade1 02/05/2018
Granted orphan drug designation by the FDA for Imbruvica for the treatment of gastric cancer, including gast…
5.SugarDaddy 04/05/2018
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Samsung Bioepis
6.pierceton 01/26/2018
Sees FY18 EPS of $7.33-7.43 from $6.37-6.57
7.pierceton 01/26/2018
ABBV leads the way today as the best performing large cap stock, closing up 13.77%.
8.nomaam4565 05/24/2018
Goldman Sachs removes from conviction buy list
9.dianamoonblade1 06/08/2018
AbbVie Announces U.S. FDA Approval of VENCLEXTA® (venetoclax tablets) in Combination with Rituximab as a Fixed Duration Treatment for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patient
10.pierceton 04/10/2018
Announces the Phase 3 upadacitinib trial met the primary endpoints of ACR20 and clinical remission versus pl…
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW